PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
27255535-8	2016	Based on these data, we hypothesized that the combination of the mTOR inhibitor rapamycin and the antiandrogen enzalutamide would have efficacy in LAR models.	enzalutamide	111-123	protein tyrosine phosphatase receptor type F	Homo sapiens	147-150